A high-density microfluidic bioreactor for the automated manufacturing of CAR T cells

Related articles

1. Cell-derived Nanoparticles Provide a Robust Platform to Manufacture Therapeutic T cells.

   This article has 35 authors:

   1. James Riley
   2. Mosha Deng
   3. Tanishk Sinha
   4. Meizan Lai
   5. Shuguang Jiang
   6. Hong Kong
   7. Vincent Cooper
   8. Meidi Gu
   9. Jonah Perelman
   10. Caimei Zhang
   11. Chiquita Hanindya
   12. Victor Carpio
   13. Peter Keller
   14. Julie Jadlowsky
   15. Rachel Leskowitz
   16. Stephen McKenna
   17. Megan Four
   18. Jesus Barranco
   19. Natalie Cooper
   20. Ankita Jain
   21. Mercy Gohil
   22. Kathleen Haines
   23. Laura Gerique
   24. Athena Russell
   25. Irina Kulikovskaya
   26. Vanessa Gonzalez
   27. Joseph Fraietta
   28. Gabriela Plesa
   29. Neil Sheppard
   30. Megan Davis
   31. Anne Chew
   32. Noelle Frey
   33. Carl June
   34. Jakub Svoboda
   35. Elizabeth Hexner

2. Respiring cultureware for high-density, scalable, multipurpose cell-based bioproduction

   This article has 18 authors:

   1. Colin Cook
   2. Austin Santiago
   3. Nicholas Scianmarello
   4. Seonah Kang
   5. Anthony Park
   6. Aishwarya Churi
   7. Hector Santiago
   8. Gabriel Zwillinger
   9. Hai Li
   10. Shyambabu Chaurasiya
   11. Jianfei Chao
   12. Yang Liu
   13. Yanhong Shi
   14. Nicole Bergman
   15. Saswati Chatterjee
   16. Yu-Chong Tai
   17. Yuman Fong
   18. Christopher Thanos

3. Breaking the Barriers in CAR-T Cell Therapy: Addressing Toxicity, Tumor Microenvironment Suppression, Persistence Challenges, and Trafficking Deficits

   This article has 7 authors:

   1. Iqra Ajmal
   2. Bingtan Du
   3. Na Huang
   4. Qianying Huang
   5. Dan Jiang
   6. Muhammad Asad Farooq
   7. Guangxian Xu